Having problems with message search?
You are receiving this message as a subscriber to the FDA HIV/AIDS electronic list serve. The purpose of the list serve is to relay important information about HIV/AIDS-related products and issues, including product approvals, significant labeling changes, safety warnings, notices of upcoming public meetings and alerts to proposed regulatory guidances for comment.
Please do not respond to this message.
The Food and Drug Administration has developed a web page to consolidate records of advisory committee meetings related to HIV/AIDS and associated conditions, making them easier to access.
The new page, which lists HIV/AIDS-related advisory committee meetings held since 1996, indexed by topic and by year, can be found at http://www.fda.gov/oashi/aids/advisorycom.html
The page is linked from the main HIV/AIDS page at http://www.fda.gov/oashi/aids/hiv.html
The page contains records of meeting held by advisory committees related to drugs, biologics, and medical devices, and will be updated to reflect availability of records of future meetings. Most records contain a variety of documents, such as the meeting announcement, committee rosters, briefing materials - which often contain background materials and slides, and transcripts of the meetings.
Topics include consideration of new drug applications, regulatory policy issues, and trial design topics.
The page also contains a link to the main FDA Advisory Committee page for other resources and topics related to FDA advisory committee meetings.
We hope you this new page useful.
Richard Klein
Office of Special Health Issues
Food and Drug Administration
Kimberly Struble
Division of Antiviral Drug Products
Food and Drug Administration
To UNSUBSCRIBE from this list, or change your e-mail address, please go to
Send Email